Get started
Author

Philip E.D. Chung

Observed names: Eu Ddeum Chung, Philip E D Chung, Philip E. D. Chung, Philip ED Chung, Philip. E.D. Chung, Philip.E Chung
ORCID: 0000-0002-3443-3088
Observed ORCID: 0000-0002-3443-3088
OpenAlex ID: A5059656991
RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation
2016 · Robert A. Jones, Tyler J. Robinson, et al. · Journal of Clinical Investigation · 147
PDF
Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and Metastasis
2017 · Eldad Zacksenhaus, Mariusz Shrestha, et al. · Trends in cancer · 142
RB1 and p53 at the crossroad of EMT and triple-negative breast cancer
2011 · Zhe Jiang, Robert Jones, et al. · Cell Cycle · 125
PDF
Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast
2018 · Yeji An, Jessica R. Adams, et al. · Cell Reports · 63
PDF
Recent acquisition of imprinting at the rodent Sfmbt2 locus correlates with insertion of a large block of miRNAs
2011 · Qianwei Wang, Jacqueline Chow, et al. · BMC Genomics · 54
PDF
Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy
2020 · Philip E. D. Chung, Deena M. A. Gendoo, et al. · Nature Communications · 36
PDF
shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
2014 · Tao Deng, Jeff C. Liu, et al. · Cancer Research · 35
Targeting HER2+ breast cancer: the TBK1/IKK-Epsilon axis
2014 · Zhe Jiang, Jeff C. Liu, et al. · Oncoscience · 29
PDF
Novel racemosin B derivatives as new therapeutic agents for aggressive breast cancer
2018 · Xiao Xiao, Mei Xu, et al. · Bioorganic & Medicinal Chemistry · 23
Hypophosphorylated pRb knock‐in mice exhibit hallmarks of aging and vitamin C‐preventable diabetes
2022 · Zhe Jiang, Huiqin Li, et al. · The EMBO Journal · 20
PDF
CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges ahead
2018 · Eldad Zacksenhaus, Jeff C. Liu, et al. · Molecular & Cellular Oncology · 15
PDF
Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer
2023 · Zhe Jiang, YoungJun Ju, et al. · Nature Communications · 12
PDF
Pre-Clinical Studies of a Novel Bispecific Fusion Protein Targeting C3b and VEGF in Neovascular and Nonexudative AMD Models
2024 · Yeri Lee, Donggeon Kim, et al. · Ophthalmology and Therapy · 9
Recent Advances in Pineoblastoma Research: Molecular Classification, Modelling and Targetable Vulnerabilities
2025 · Zhe Jiang, Michelle S. Allkanjari, et al. · Cancers · 7
PDF
A racemosin B derivative, C25, suppresses breast cancer growth via lysosomal membrane permeabilization and inhibition of autophagic flux
2022 · Xiao Xiao, Philip. E.D. Chung, et al. · Biochemical Pharmacology · 4
A temporal in vivo catalog of chromatin accessibility and expression profiles in pineoblastoma reveals a prevalent role for repressor elements
2023 · Salam Idriss, Mohammad Hallal, et al. · Genome Research · 3
PDF
Methylation data of mouse Rb-deficient pineoblastoma
2020 · Philip E.D. Chung, Eldad Zacksenhaus · Data in Brief · 2
PDF
Thinking (Metastasis) outside the (Primary Tumor) Box
2023 · Zhe Jiang, Young-Jun Ju, et al. · Cancers · 1
PDF
Data from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
2023 · Tao Deng, Jeff C. Liu, et al.
Supplementary Figure 6 from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
2023 · Tao Deng, Jeff C. Liu, et al.
PDF
Supplementary Figure 5 from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
2023 · Tao Deng, Jeff C. Liu, et al.
PDF
Supplementary Figure 7 from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
2023 · Tao Deng, Jeff C. Liu, et al.
Supplementary Figure 4 from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
2023 · Tao Deng, Jeff C. Liu, et al.
Supplementary Figure 1 from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
2023 · Tao Deng, Jeff C. Liu, et al.
PDF
Supplementary Figure 2 from shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer
2023 · Tao Deng, Jeff C. Liu, et al.
PDF
Works count: 49
Citation count: 727
H-index: 12
I10-index: 12
Year
Topic
Type